Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP614588.RABraCR0xLWZY813EueGEQuulwpz_ZJ1wtx-Dy2VWDBLs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP614588.RABraCR0xLWZY813EueGEQuulwpz_ZJ1wtx-Dy2VWDBLs130_assertion type Assertion NP614588.RABraCR0xLWZY813EueGEQuulwpz_ZJ1wtx-Dy2VWDBLs130_head.
- NP614588.RABraCR0xLWZY813EueGEQuulwpz_ZJ1wtx-Dy2VWDBLs130_assertion description "[The ENPP1 121Gln and IRS-1 972Arg polymorphisms affecting insulin receptor activity predispose to liver damage and decrease hepatic insulin signalling in patients with NAFLD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614588.RABraCR0xLWZY813EueGEQuulwpz_ZJ1wtx-Dy2VWDBLs130_provenance.
- NP614588.RABraCR0xLWZY813EueGEQuulwpz_ZJ1wtx-Dy2VWDBLs130_assertion evidence source_evidence_literature NP614588.RABraCR0xLWZY813EueGEQuulwpz_ZJ1wtx-Dy2VWDBLs130_provenance.
- NP614588.RABraCR0xLWZY813EueGEQuulwpz_ZJ1wtx-Dy2VWDBLs130_assertion SIO_000772 20176643 NP614588.RABraCR0xLWZY813EueGEQuulwpz_ZJ1wtx-Dy2VWDBLs130_provenance.
- NP614588.RABraCR0xLWZY813EueGEQuulwpz_ZJ1wtx-Dy2VWDBLs130_assertion wasDerivedFrom befree-20150227 NP614588.RABraCR0xLWZY813EueGEQuulwpz_ZJ1wtx-Dy2VWDBLs130_provenance.
- NP614588.RABraCR0xLWZY813EueGEQuulwpz_ZJ1wtx-Dy2VWDBLs130_assertion wasGeneratedBy ECO_0000203 NP614588.RABraCR0xLWZY813EueGEQuulwpz_ZJ1wtx-Dy2VWDBLs130_provenance.